BIOMAT Database Logo BIOMAT Database Logo

Tyrosine augments clozapine-induced dopamine release in the medial prefrontal cortex of the rat in vivo: effects of access to food. 2004

George E Jaskiw, and Catherine Simpson, and Rodolfo Bongiovanni, and Bryan K Yamamoto
Psychiatry Service 116A(B), Louis Stokes Cleveland Veterans Affairs Medical Center, 10000 Brecksville Road, Brecksville, OH 44141, USA. george.jaskiw@case.edu

It has been reported that tyrosine administration augments clozapine-induced dopamine (DA) release in the medial prefrontal cortex (MPFC). To characterize this effect and exclude possible confounds, we conducted a series of studies in which microdialysate collection started 24 h after probe implantation, a time at which most collected DA is thought to be impulse mediated. Tyrosine (25 or 50 mg/kg IP) administered 30 min after clozapine (10 mg/kg IP) augmented clozapine-induced MPFC but not striatal DA release. While tyrosine potentiation was also evident in both fasted animals and those with free access to food, the effective doses of tyrosine varied. We confirm that tyrosine administration can potentiate clozapine-induced MPFC DA release but note that the effect is not evident across all doses and conditions.

UI MeSH Term Description Entries
D009434 Neural Pathways Neural tracts connecting one part of the nervous system with another. Neural Interconnections,Interconnection, Neural,Interconnections, Neural,Neural Interconnection,Neural Pathway,Pathway, Neural,Pathways, Neural
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder

Related Publications

George E Jaskiw, and Catherine Simpson, and Rodolfo Bongiovanni, and Bryan K Yamamoto
Tyrosine augments acute clozapine- but not haloperidol-induced dopamine release in the medial prefrontal cortex of the rat: an in vivo microdialysis study.
July 2001, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
George E Jaskiw, and Catherine Simpson, and Rodolfo Bongiovanni, and Bryan K Yamamoto
Clozapine-induced dopamine release in the medial prefrontal cortex is augmented by a moderate concentration of locally administered tyrosine but attenuated by high tyrosine concentrations or by tyrosine depletion.
June 2005, Psychopharmacology,
George E Jaskiw, and Catherine Simpson, and Rodolfo Bongiovanni, and Bryan K Yamamoto
In rats chronically treated with clozapine, tyrosine depletion attenuates the clozapine-induced in vivo increase in prefrontal cortex dopamine and norepinephrine levels.
May 2006, Psychopharmacology,
George E Jaskiw, and Catherine Simpson, and Rodolfo Bongiovanni, and Bryan K Yamamoto
Effects of the serotonin2A/2C receptor agonist and antagonist on phencyclidine-induced dopamine release in rat medial prefrontal cortex.
October 1999, Progress in neuro-psychopharmacology & biological psychiatry,
George E Jaskiw, and Catherine Simpson, and Rodolfo Bongiovanni, and Bryan K Yamamoto
Characterization of dopamine release in the rat medial prefrontal cortex as assessed by in vivo microdialysis: comparison to the striatum.
January 1990, Neuroscience,
George E Jaskiw, and Catherine Simpson, and Rodolfo Bongiovanni, and Bryan K Yamamoto
Tyrosine augments dopamine release in stimulated rat retina.
November 1992, Brain research,
George E Jaskiw, and Catherine Simpson, and Rodolfo Bongiovanni, and Bryan K Yamamoto
Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens.
February 2009, Neuropharmacology,
George E Jaskiw, and Catherine Simpson, and Rodolfo Bongiovanni, and Bryan K Yamamoto
Evoked extracellular dopamine in vivo in the medial prefrontal cortex.
August 1993, Journal of neurochemistry,
George E Jaskiw, and Catherine Simpson, and Rodolfo Bongiovanni, and Bryan K Yamamoto
Effects of repeated cocaine on the release and clearance of dopamine within the rat medial prefrontal cortex.
February 2005, Synapse (New York, N.Y.),
George E Jaskiw, and Catherine Simpson, and Rodolfo Bongiovanni, and Bryan K Yamamoto
(R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex.
August 1993, Acta physiologica Scandinavica,
Copied contents to your clipboard!